title: [Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures].
abstract: OBJECTIVE
  To assess daily practice of 1000 sentinel node (SN) biopsies in breast cancer.
  
  
  METHODS
  Prospective review of 1000 consecutive sentinel node biopsies between February 2001 and June 2004. Analyses concerned technical aspects of sentinel node detection, pathologic results of the tumor and sentinel node, treatment and follow-up.
  
  
  RESULTS
  Nine hundred and seventy-eight SN were detected (98.7%). In univariate analyses, age, pathologic tumor size (20 mm) and method of detection (blue dye or isotopic vs. combined) were statistically significant. One hundred and fifty-six cases (16%) underwent immediate axillary dissection (AD), whereas 116 (12%) had a delayed AD. There were 923 invasive or micro-invasive carcinoma with detected SN: 282 SN (30.5%) were involved, either with macrometastases (166) or with micrometastases (116), 34% had positive non-sentinel node. Age and metastasis size were predictive for AD involvement. Sixteen percent of micrometastatic SN had positive AD, there was no predictive factor for axillary involvement. After a median follow-up of 20 months, there were 4 axillary recurrences: 1 (0.1%) after negative SN without AD, 1 (0.1%) after positive SN with positive AD, 1 (4.3%) after micrometatastatic SN without AD, and 1 (8.3%) after macrometastatic SN without AD. There were 55 ductal carcinoma in situ and 54 micro-invasive cancer: positive SN (with negative AD) were detected in only 2 cases (2.3%). There were initially 112 ductal carcinoma in situ diagnosed by percutaneaous biopsy, 25 of them (22%) had invasive disease on definitive histology. Among there, 12 had involved SN (with 4 positive AD).
  
  
  CONCLUSIONS
  With a high detection rate and low recurrence rate, SN biopsy is considered in our institute as a reliable procedure and is used to evaluate regional nodal status of early breast cancer. Thus, 70% of AD can be omitted.
authors.affiliation: Département de sénologie, centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59020 Lille cedex, France. sylvia.giard@wanadoo.fr
authors.forename: S
authors.initials: S
authors.lastname: Giard
authors.forename: M-P
authors.initials: MP
authors.lastname: Chauvet
authors.forename: J-L
authors.initials: JL
authors.lastname: Houpeau
authors.forename: M-C
authors.initials: MC
authors.lastname: Baranzelli
authors.forename: P
authors.initials: P
authors.lastname: Carpentier
authors.forename: C
authors.initials: C
authors.lastname: Fournier
authors.forename: Y
authors.initials: Y
authors.lastname: Belkacemi
authors.forename: J
authors.initials: J
authors.lastname: Bonneterre
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001365:Axilla; D001943:Breast Neoplasms / Q000473:pathology*; D005260:Female; D006801:Humans; D008197:Lymph Node Excision / Q000706:statistics & numerical data*; D008207:Lymphatic Metastasis / Q000175:diagnosis; D008875:Middle Aged; D021701:Sentinel Lymph Node Biopsy / Q000706:statistics & numerical data*